期刊文献+

基质金属蛋白酶MMP-2在口腔鳞癌中的表达及意义 被引量:2

Expressions of MMP-2 in Oral Squamous Cell Carcinoma and Clinical Significance
下载PDF
导出
摘要 目的分析基质金属蛋白酶(MMP-2)在口腔鳞癌中的表达及与临床病理之间的关系,为口腔鳞癌的诊断提供一个新的指标。方法收集50例手术临床病理证实口腔鳞癌手术标本。用免疫组化法检测MMP-2的表达。数据资料应用SPSS17.0统计学软件处理。结果 MMP-2的表达水平与口腔鳞癌淋巴结转移有关、有统计学意义(P<0.05),与口腔磷癌组织学类型、分化程度无关(P>0.05)。结论 MMP-2可以作为评价口腔鳞癌侵袭和转移能力指标。 Objective To observe the expression of Matrix Metalloproteinase-2in Oral Squamous Cell Carcinom and their relationships with clinicopathologic features.To support a new predictive and a new pathway to the treatment of the rectal carcinoma.Methods In this research 50 paraffin-embedded cancer biopsy specimens of patients with rectal carcinoma who had been proved to have Oral Squamous Cell Carcinom through pathological diagnosis and had operation for cure Routine slice is done for 2 serial section in 3 m thickness,and used to detect the expression level of MMP-2 with the appliance of SP.The data have been statistically analyzed with spss 13.0 for windows.Results And there are no significant statistical differences in MMP-2 expressions among the tumor location,growth style,histological type,differentiated degrees of the patients respectively(p0.05).There are significant differences in MMP-2 expression in Lymph node metastasis(P0.05).Conclusion MMP-2 can be used to appraise the latent energy of invasion and metastasis in Oral Squamous Cell Carcinoma.
作者 于艳 张安玲
出处 《中国实验诊断学》 北大核心 2011年第6期1067-1068,共2页 Chinese Journal of Laboratory Diagnosis
关键词 基质金属蛋白酶MMP-2 口腔鳞癌 侵袭转移 Matrix Metalloproteinase-2 Oral Squamous Cell Carcinoma Invasion metastasis
  • 相关文献

参考文献2

二级参考文献12

  • 1赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 2谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 3McKenna GJ, Meneghetti A, Chen YL, et ol. Predictive value of lymph node and tumor matrix metalloproteinase expression in the analysis of metastatic periampullary tumors[J]. J Surg Oncol,2005,90(4) : 239 - 246.
  • 4Fujiwara A, Shibata E, Terashima H, et ol. Evaluation of matrix metalloproteinase-2(MMP-2) activity with film in situ zymography for improved cytological diagnosis of breast tumors[J]. Breast Cancer, 2006, 13(3) :272 - 278.
  • 5Nasr M, Ayyad SB, El-Lamie IK, et al. Expression of matrix metalloproteinase -2 in preinvasive and invasive carcinoma of the uterine cervix [J]. Eur J Gynaecol Oncol, 2005,26(2):199-202.
  • 6De Vicente JC, Fresno MF, Villalain L, et al. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase- 9 in oral squamous cell carcinoma[J]. Oral Oncol, 2005,41(3):283 - 293.
  • 7Zhang Y, Wang C, Mizukami H, et al. Increased expression and activation of matrix metalloproteinase-2 (MMP-2) in O-IN: hamster oral squamous cell carcinoma with high potential lymph node metastasis[J]. J Exp Clin Cancer Res, 2006, 25(3):417-423.
  • 8Kleijn DP, Sluijter JP, Smit J, et al. Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling[J]. FELLS Lett, 2001,501(1):37 -41.
  • 9Qu xj, Yuan YX, Tian ZG, et ol. Using caffeoyl pyrrolidine derivative LY52, a potential inhibitor of matrix metalloproteinase-2, to suppress tumor invasion and metastasis[J]. Int J Mol Med, 2006, 18(4) : 609-614.
  • 10Zheng H, Takahashi H, Murai Y, et al. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma[J]. Anticancer Res, 2006,26 (5A) . 3579 - 3583.

共引文献1365

同被引文献27

  • 1雷志敏,张敏,赵怡芳.MMP-2、MMP-9及肿瘤抑制基因FHIT在口腔鳞癌组织中的表达[J].武汉大学学报(医学版),2007,28(2):188-191. 被引量:3
  • 2Lerman J,Johr M. Inhalational anesthesia vs total intravenous anes-thesia (TIVA) for pediatric anesthesia. Paediatr Anaesth, 2009, 19(5):521-534.
  • 3Jun H, Gui-he Z, Xing-xing S, et al. Isoflurane enhances malignan-cy of head and neck squamous cell carcinoma cell lines : a preliminarystudy in vitro. Oral Oncol,2011,47(5) :329-333.
  • 4Taipale J, Saharinen J, Keski-Oja J. Extracellular matrix-associatedtransforming growth factor-beta : role in cancer cell growth and inva-sion. Adv Cancer Res, 1998,75 : 87-134.
  • 5Denys H,Braems G,Lambein K, et al. The extracellular matrixregulates cancer progression and therapy response: implications forprognosis and treatment. Curr Pharm Des,2009,15( 12) : 1373-1384.
  • 6Nasr M, Ayyad SB, El-Lamie IK, et al. Expression of matrix metal-loproteinase-2 in preinvasive and invasive carcinoma of the uterinecervix. Eur J Gynaecol Oncol,2005,26( 2) : 199-202.
  • 7Fang J, Shing Y, Wiederschain D, et al. Matrix metalloproteinase-2is required for the switch to the angiogenic phenotype in a tumor mod-el. Proc Natl Acad Sci U S A, 2000 f 97( 8) : 3884-3889.
  • 8de Vicente JC, Fresno MF, Villalain L, et al. Expression and clini-cal significance of matrix metalloproteinase-2 and matrix metallopro-teinase-9 in oral squamous cell carcinoma. Oral Oncol, 2005,41(3):283-293.
  • 9Roh J, Muelieman T, Tawfik O, et al. Perineural growth in head and neck squamous cell carcinoma: A review [J]. Oral Oncol, 2015, 51(1) : 16-23.
  • 10O-charoenrat P, Modjtahedi H, Rhys-Evans P, et al. Ep- idermal growth {actor- like ligands diilerentially up- regu- late matrix metalloproteinase 9 in head and neck squamous carcinoma cells [J]. Cancer Res, 2000, 60(4) : 1121-8.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部